Efficacy and Safety of FTY720 for the Treatment of Acute Stroke
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2018
Price : $35 *
At a glance
- Drugs Fingolimod (Primary) ; Alteplase
- Indications Stroke
- Focus Proof of concept; Therapeutic Use
- 08 Oct 2018 Primary endpoint (the favorable shift of modified Rankin scale score (mRS) distribution at day 90) has been met.
- 08 Oct 2018 Results published in the Annals of Neurology
- 22 Jul 2015 Status changed from recruiting to completed according to the results published in the Circulation according to the results published in the Circulation.